Learn More

image from Freepik


General Knowledge



Sickle cell disease started as a genetic mutation in the beta-globin gene many generations ago. This mutation changes the shape of hemoglobin, producing a type called HbS instead of the normal HbA.

Sickle cell disease is most common in people whose ancestors come from parts of Africa, the Mediterranean, the Middle East, and India, because the sickle gene originally helped protect against malaria, which is a serious disease spread by mosquitoes. However, it can affect anyone if the genes are passed down.

Through history, people with one copy of the sickle gene were more likely to overcome malaria infections and survive and have children, thus pass that gene on to their children.

Piel, F. B., Steinberg, M. H., & Rees, D. C. (2017). Sickle cell disease. New England Journal of Medicine, 376(16), 1561–1573.


When a person has sickle cell disease, their red blood cells make a lot of HbS, the abnormal form of hemoglobin. Normally, hemoglobin carries oxygen without sticking together. But in HbS, the hemoglobin molecules can clump together, especially when oxygen levels in the blood drop, like during exercise or illness. This clumping changes the shape of the red blood cells, bending them from their normal round, flexible shape into a crescent or “sickle” shape.

These sickle-shaped cells are stiff and sticky. Because they can’t bend and flow smoothly like normal red blood cells, they often get stuck in small blood vessels. This can block blood flow, causing painful episodes, making organs work harder, and reducing the amount of oxygen that reaches the body.

Sickle cells also die much faster than normal red blood cells. While normal red blood cells last about 3–4 months, sickle cells only last 10–20 days. This rapid breakdown leads to a shortage of red blood cells, called anemia, which makes the body feel tired, weak, and short of energy.

Cleveland Clinic. (2024, August 21). Sickle cell anemia. Cleveland Clinic Health Library.


One of the most common signs of sickle cell disease is anemia, which can make someone feel constantly tired, weak, or short of breath, even during everyday activities. You might notice pale skin or lips, because there aren’t enough healthy red blood cells carrying oxygen. Pain episodes, also called “crises,” are another hallmark symptom. 

Whitbourne, K. (2024, September 25). What is pernicious anemia? WebMD

These sudden episodes can cause sharp pain in the bones, joints, chest, or abdomen and can last hours or days. Swelling in the hands and feet is also common, especially in young children, and can be an early sign of blocked blood flow.

These symptoms can lead to more serious complications over time. For example, repeated pain crises and blocked blood vessels can cause organ damage, affecting the liver, kidneys, heart, and lungs. Strokes may occur if blood flow to the brain is blocked by sickle cells. Acute chest syndrome, a dangerous blockage in the lungs’ blood vessels, can cause severe chest pain, fever, and difficulty breathing.

Over time, these complications can make the body less able to cope with stress, illness, or infections, which is why careful monitoring, treatment, and education are crucial for people with sickle cell disease.


Treatments

image from Freepik


Sickle cell disease can be diagnosed shortly after birth through a simple blood test called a newborn screening, which checks for the presence of abnormal hemoglobin. The diagnosis may involve a blood test called a hemoglobin electrophoresis, which identifies the types of hemoglobin in the blood and confirms whether a person has HbA, HbS, or both.

Medications are an essential part of managing sickle cell disease. Hydroxyurea is a commonly prescribed drug that works by increasing the production of fetal hemoglobin (HbF), a type of hemoglobin that does not sickle. Higher levels of HbF help prevent red blood cells from forming the sickle shape, reduce pain crises, and lower the risk of complications such as acute chest syndrome.


Regular blood transfusions are sometimes recommended for people with severe sickle cell disease. Transfusions work by adding healthy red blood cells into the bloodstream, which helps increase oxygen delivery and reduce the number of sickle cells. This treatment can lower the risk of stroke in children, reduce severe anemia, and prevent complications in high-risk patients.

A bone marrow or stem cell transplant is currently the only treatment that can potentially cure sickle cell disease. In this procedure, a patient’s bone marrow, which produces red blood cells, is replaced with healthy marrow from a compatible donor. This allows the body to start producing normal hemoglobin and red blood cells. Transplants are most successful when performed in children, but they are complex procedures with significant risks, including infection or the body rejecting the donor marrow. Because of these risks, transplants are usually reserved for patients with severe disease or complications.


Treatments